Skp2: A novel potential therapeutic target for prostate cancer
- 31 January 2012
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1825 (1) , 11-17
- https://doi.org/10.1016/j.bbcan.2011.09.002
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Skp2 Overexpression Is Associated with Loss of BRCA2 Protein in Human Prostate CancerThe American Journal of Pathology, 2011
- Nuclear PTEN Regulates the APC-CDH1 Tumor-Suppressive Complex in a Phosphatase-Independent MannerCell, 2011
- Emerging roles of PDGF-D signaling pathway in tumor development and progressionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescenceNature, 2010
- Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKBNature Cell Biology, 2009
- Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destructionNature Cell Biology, 2009
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotypeHuman Pathology, 2008
- Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancerNature Reviews Cancer, 2008
- Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotypeBritish Journal of Cancer, 2008